Skip to content

A Clinical Study to Evaluate the Safety of a Personal Lubricant in Healthy Female Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02737592
Enrollment
34
Registered
2016-04-14
Start date
2016-03-31
Completion date
2016-04-30
Last updated
2017-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Edema, Erythema

Brief summary

To evaluate the safety of a personal lubricant when used at least four times weekly for two weeks (including at least twice weekly during sexual intercourse for subjects with monogamous male partners), in a population consisting of healthy females.

Interventions

DEVICETrojan Simply Pleasure Personal Lubricant

silicone base without sensate

Sponsors

Church & Dwight Company, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* no participation in a similar study 2-weeks prior * may be post-menopausal or have had a hysterectomy * if sexually active, and of child bearing potential, subjects is using adequate non-barrier method of birth control * free from any vaginal disorders * sexually active and in a monogamous, heterosexual relationship, and whose male partner is willing and able to give informed consent and agrees to engage in sexual intercourse at least twice each week during the two-week study or is not sexually active * personal lubricant user and agrees to replace her usual personal lubricant with the investigational product * can start regardless of where they are in their cycles * agrees to use the provided investigational product at least four time weekly over the two week study period * exhibits no clinically significant evidence of vulvar or vaginal irritation, as determined by a study doctor, and no reports of sensory irritation at the baseline exam * willing to refrain from introducing any new vaginal products, or using vaginal medications or local contraceptives during study * agrees to refrain from douching or using any medications, powder, lotions or personal care products in the vulvar or perianal area * willing to use a urine pregnancy test provided to them at baseline and on third visit * standard medical history form on file * signed informed consent * completed HIPAA * dependable and able to follow directions as outlined * receives a score of 0 or 0.5 for erythema and edema; and 0 for sensorial irritation (burning, stinging, itching and dryness) during the first examination.

Exclusion criteria

* pregnant, nursing or planning a pregnancy * currently using or has used within two weeks prior to the study initiation, any systemic or topical corticosteroids, vasoconstrictors, antibiotics, anti-inflammatories or antihistamines * known allergies to vaginal or any cosmetic products * reports history of recurrent bladder, vaginal infections or incontinence * exhibits or reports gynecologic abnormalities or has had vaginitis within 60 days prior to study initiation * uses a vaginal ring, diaphram or cervical/vault caps, condoms, or condoms with spermicide as a means of contraception * participated in a study involving the vaginal area or in an investigational systemic drug study within two weeks of study initiation * receives a score higher than 0/5 for erythema, edema or \>0 for burning, stinging, or itching, during first examination or shows any other sign of mucosal irregularities

Design outcomes

Primary

MeasureTime frameDescription
Number of Subjects With Observed Local Erythema Based on 5 Point Scale2 weeksNumber of subjects with observed local erythema by OB/GYN examination as graded on 5 point clinical scale: 0 = normal appearance no irritation, 0.5 = slight, irregular erythema, 1 = mild erythema, 2 = moderate erythema 3 = severe erythema
Number of Subjects With Observed Edema Based on the 5 Point Scoring Scale2 weeksNumber of subjects with observed local edema by OB/GYN examination as graded on 5 point clinical scale: 0 = normal appearance no edema, 0.5 = slight edema, 1 = mild edema, 2 = moderate edema 3 = severe edema

Countries

United States

Participant flow

Participants by arm

ArmCount
Healthy Subject
Healthy subject exposed to Trojan Simply Pleasures Personal Lubricant at least four times weekly for two weeks Trojan Simply Pleasure Personal Lubricant: silicone base without sensate
33
Total33

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicHealthy Subject
Age, Customized
Age 20 - 60
33 Participants
Sex: Female, Male
Female
33 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 33
serious
Total, serious adverse events
0 / 33

Outcome results

Primary

Number of Subjects With Observed Edema Based on the 5 Point Scoring Scale

Number of subjects with observed local edema by OB/GYN examination as graded on 5 point clinical scale: 0 = normal appearance no edema, 0.5 = slight edema, 1 = mild edema, 2 = moderate edema 3 = severe edema

Time frame: 2 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Healthy SubjectNumber of Subjects With Observed Edema Based on the 5 Point Scoring Scale0 Participants
Primary

Number of Subjects With Observed Local Erythema Based on 5 Point Scale

Number of subjects with observed local erythema by OB/GYN examination as graded on 5 point clinical scale: 0 = normal appearance no irritation, 0.5 = slight, irregular erythema, 1 = mild erythema, 2 = moderate erythema 3 = severe erythema

Time frame: 2 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Healthy SubjectNumber of Subjects With Observed Local Erythema Based on 5 Point Scale0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026